VALN
Closed
Valneva Se Adr
7.
0 (0.00%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 7.
Day's Range: 6.93 - 7.19
Send
sign up or login to leave a comment!
When Written:
11.2199
Valneva SE is a French biotech company that specializes in developing vaccines for infectious diseases. It was founded in 2013 and is headquartered in Saint-Herblain, France. The company's vaccine portfolio includes vaccines for Lyme disease, chikungunya, and COVID-19.
Valneva SE is listed on the Euronext Paris stock exchange and also has American Depositary Receipts (ADRs) listed on the Nasdaq stock exchange in the United States. Each ADR represents one ordinary share of Valneva SE.
As of August 2021, Valneva SE ADRs are trading at around $27 per share, with a market capitalization of approximately $1.4 billion. The company has partnerships with various organizations, including the UK government and the Coalition for Epidemic Preparedness Innovations (CEPI), to develop and manufacture vaccines.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Valneva SE is listed on the Euronext Paris stock exchange and also has American Depositary Receipts (ADRs) listed on the Nasdaq stock exchange in the United States. Each ADR represents one ordinary share of Valneva SE.
As of August 2021, Valneva SE ADRs are trading at around $27 per share, with a market capitalization of approximately $1.4 billion. The company has partnerships with various organizations, including the UK government and the Coalition for Epidemic Preparedness Innovations (CEPI), to develop and manufacture vaccines.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!